Developemental Research Program

开发研究计划旨在开发创新的前列腺癌翻译 研究。因此，它支持新颖的翻译研究项目或具有一定潜力的研究项目 为今后的翻译研究提供科学依据。这一计划对中国的 前列腺孢子的成功是因为它使人们能够积极主动地识别和支持创新 假设驱动的研究。这种支持的可获得性也刺激了 研究社区，鼓励基础科学家和翻译人员互动的工具 研究人员，以及通过寻找新线索来扩大孢子研究范围的机会 基于发现和/或出现的机会。我们在申请中申请了100,000美元，以 支持这一计划。此外，梅奥将为发展研究额外提供50,000美元 计划(见梅奥首席执行官兼董事会主席休·史密斯博士的承诺书 罗切斯特诊所和梅奥基金会副总裁)。因此，我们计划总共拨款150,000元，以 发展研究计划。

The Developmental Research Program is designed to develop innovative prostate cancer translational research. As such, it supports novel translational research projects or research projects with definite potential to provide a scientific base for future translational research. This program is of great importance to the success of the Prostate SPORE because it enables a proactive stance in identifying and supporting innovative hypothesis-driven research. The availability of this support also provides a stimulus for creativity in the research community, a vehicle for encouraging the interaction of basic scientists and translational investigators, and an opportunity for expanding the research spectrum of the SPORE by pursuing new leads based on discoveries and/or opportunities that arise. We have requested $100,000 in the application to support this program. In addition Mayo will provide an additional $50,000 for the Developmental Research Program (See letter of commitment from Dr. Hugh Smith, CEO and Chair of the Board of Governors of Mayo Clinic, Rochester, and Vice President of the Mayo Foundation). Thus, we plan to commit a total of $150,000 to the Developmental Research Program.